Pharmaceutical Technology on MSN
MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority
The FDA has scheduled a decision date for 10 October 2026 under the Prescription Drug User Fee Act.
A new approach reveals unexpected ways oxygen can bind to rare metals. Iron plays a central role in how the body uses oxygen. In hemoglobin, it binds dioxygen, a pair of oxygen atoms, allowing blood ...
Iron and oxygen bind together throughout the body. Most famously, iron binds dioxygen, or two oxygens paired with each other, in hemoglobin that transports oxygen through blood. But iron-oxo compounds ...
Biochemistry is the branch of science that investigates the chemical substances, reactions, and molecular mechanisms underlying biological processes in living organisms. It focuses on the structure, ...
Ligand Pharmaceuticals continues to outperform, driven by its high-margin, diversified royalty model and disciplined investment approach. LGND’s transition in 2022 to a capital and technology provider ...
Ligand Pharmaceuticals (LGND) traded higher in the premarket on Wednesday after Bank of America launched its coverage with a Buy recommendation and a $244 target, citing its high-margin but less risky ...
5 analysts have shared their evaluations of Ligand Pharmaceuticals (NASDAQ:LGND) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a ...
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
This study presents a valuable finding about how receptor–ligand binding pathways with multi-site phosphorylation can show non-monotonic responses to increasing ligand affinity and to kinase activity.
2025 full year revenue guidance increased to $200 million - $225 million (previously $180 million - $200 million) and adjusted earnings per diluted share 1 increased to $6.70 - $7.00 (previously $6.00 ...
Eneos Corp. (Tokyo) has announced the development of alkylphosphine with a triisobutylene (TIB) backbone (TIB phosphine ligand), a high-performance ligand for nickel-catalyzed coupling reactions, in ...
Recently, SandboxAQ launched what it claims is the largest publicly available dataset of protein-ligand pairs with annotated experimental binding potency data. According to the company, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results